Literature DB >> 21067409

Incomplete testosterone suppression in prostate cancer.

E David Crawford, Kyle O Rove.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21067409     DOI： 10.1056/NEJMc1010187

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

Review 1.  Maximal testosterone suppression in prostate cancer--free vs total testosterone.

Authors:  Kyle O Rove; E David Crawford; Massimo Perachino; Juan Morote; Laurence Klotz; Paul H Lange; Gerald L Andriole; Alvin M Matsumoto; Samir S Taneja; Mario A Eisenberger; Leonardo O Reis
Journal:  Urology       Date:  2014-04-06       Impact factor: 2.649

2.  Inadequate testosterone suppression after medical and subsequent surgical castration in a patient with prostate cancer.

Authors:  Oskar Ragnarsson; Gudmundur Johannsson; Kjell Geterud; Par Lodding; Per Dahlqvist
Journal:  BMJ Case Rep       Date:  2013-08-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.